Literature reviews, generated by AI

Ask a question. Get a review grounded in recent research.

PubMed research · Cited sources

Start free. Continue from $5.

6 free credits, then one-time credit packs from $5.

See credit options
Keywords the machine will use on PubMed:
If you want, you can iterate on your question.
Used by Professionals at:
MIT Charite Novartis Roche AstraZeneca USZ
Generated Reviews

Three-Dimensional Brain Visualization from Volumetric MRI Methods Clinical Applications and Evidence

Three-dimensional brain visualization from volumetric magnetic resonance imaging (MRI) combines high-resolution acquisition, preprocessing, anatomical segmentation, structural reconstruction, and interactive surface or volume rendering. The resulting patient-specific models can display cortical and subcortical anatomy, gyri, sulci, lesions, vessels, ventricles, cortical thickness, and selected functional or electrode-related data. Isotropic or near-isotropic imaging supports multiplanar reformation, whereas deformable atlas registration can improve visualization of structures that are difficult to distinguish on conventional MRI. In neurosurgical practice, MRI-based reconstructions may assist anatomical localization, trajectory selection, lesion mapping, and preoperative or intraoperative planning. Reported evidence also indicates close correspondence between reconstructed cortical anatomy and operative findings, with lesion-localization accuracy of approximately 2.6 ± 1.0 mm in one workflow. The available studies establish important acquisition and reconstruction principles, although they do not uniformly evaluate general-purpose clinical rendering systems.

Question: Give 3d view of mri brain

Read the full review

Building a Sustainable Healthy Lifestyle Through Flexible Daily Habits

Healthy living is most effectively developed through gradual, practical, and sustainable behaviors rather than rigid or extreme programs. The evidence presented supports a flexible approach centered on nutritious, minimally processed foods; regular physical activity; reduced sedentary time; adequate sleep; stress management; avoidance of tobacco; moderation of alcohol; and attention to individual circumstances. Mediterranean- and DASH-style eating patterns provide adaptable models, while walking, cycling, household activities, active transportation, and brief exercise sessions can make movement accessible. Small goals, self-regulation, social support, and professional guidance may improve adherence. Overall, consistency, enjoyment, and compatibility with personal preferences, resources, and daily responsibilities are more important than perfection.

Question: Summarize the key points of a healthy lifestyle to adopt easily and without hard constraints

Read the full review

Mechanism and Catalytic Cycle of Arginyl–tRNA Synthetase

Arginyl–tRNA synthetase (ArgRS; EC 6.1.1.19) catalyzes ATP-dependent attachment of L-arginine to cognate tRNA^Arg, producing arginyl-tRNA^Arg, AMP, and inorganic pyrophosphate. The reaction proceeds through amino-acid adenylation followed by transfer of arginine to a hydroxyl group of the terminal adenosine of tRNA. Evidence from kinetic, structural, mutational, and exchange studies indicates that Mg^2+ supports substrate binding and phosphoryl-transfer chemistry, while tRNA participates directly in formation and utilization of the activated arginine state. However, the binding order and accessibility of the Arg-AMP intermediate vary among systems: yeast studies support flexible substrate association and a tightly enzyme-associated activated state, whereas other analyses describe a detectable enzyme-bound aminoacyl-adenylate. Conformational rearrangements, pyrophosphate-dependent reversibility, and product release contribute to turnover in addition to ester-bond formation.

Question: Explain the mechanism of Arginine-tRNA ligase Q05506 UniProt EC 6.1.1.19. Explain which substrate it works on and the step by step mechanism from reactant to product

Read the full review

Pre-eclampsia as a Marker of Long-term Cardiovascular Risk

Pre-eclampsia is consistently associated with elevated cardiovascular risk extending well beyond pregnancy. Compared with women whose pregnancies are normotensive or uncomplicated, affected women have higher risks of chronic hypertension, coronary heart disease, myocardial infarction, heart failure, stroke and other cerebrovascular disease, arterial disease, cardiovascular hospitalization, and cardiovascular mortality. Across studies, later cardiovascular disease risk is generally approximately two- to fourfold higher, although estimates vary by population, outcome, and follow-up duration. Risk is particularly pronounced after early-onset, severe, preterm, or recurrent disease and when fetal growth restriction is present. The association is partly mediated by subsequent hypertension and cardiometabolic risk factors, while persistent vascular, cardiac, inflammatory, metabolic, and angiogenic abnormalities may also contribute. A history of pre-eclampsia therefore warrants lifelong cardiovascular risk assessment and prevention.

Question: what is the long term cardiovascular risk after pre-eclampsia?

Read the full review

Zerebraler Energiestoffwechsel und Perfusionsregulation bei MECFS Eine kritische Übersicht

Die Hypothesen eines veränderten zerebralen Energiestoffwechsels und einer gestörten Perfusionsregulation lassen sich bei ME/CFS bislang nur teilweise empirisch trennen. Hinweise auf Energiestress ergeben sich insbesondere aus erhöhten kortikalen Laktatwerten, während Perfusions- und Hämodynamikstudien regionale, aufgabenabhängige und orthostatisch ausgelöste Auffälligkeiten beschreiben. Einfache Modelle einer dauerhaft bestehenden globalen Hypoperfusion oder eines isolierten primären Energiestoffwechseldefekts werden durch die verfügbaren Befunde jedoch nicht hinreichend gestützt. Vielmehr sprechen die Daten für eine gekoppelte Störung von neuronaler Aktivität, Energieversorgung, Sauerstoffnutzung, Durchblutung und Erholung. Besonders relevant scheint eine unzureichende dynamische Anpassung der zerebralen Durchblutung an kognitive und orthostatische Belastungen zu sein. Zur Klärung der Kausalbeziehungen sind zeitgleiche Messungen von Perfusion, neuronaler Aktivität, Sauerstoffmetabolismus und metabolischen Reserven erforderlich.

Question: Brain-Fog bei ME/CFS: Mich würde interessieren, wie gut sich die Hypothese von verändertem Energiestoffwechsel vs. Perfusionsstörungen empirisch trennen lässt.

Read the full review

Drug-Coated Balloon Versus Stenting in Acute Coronary Syndrome and Coronary Artery Disease A Focused Review

Drug-coated balloon (DCB) treatment is a potential alternative to stenting in selected coronary lesions, but its comparative role across acute coronary syndrome (ACS) and stable coronary artery disease (CAD) remains uncertain. Available evidence includes small randomized ACS trials, randomized studies in stable small-vessel disease, randomized evidence in de novo non-complex CAD, and observational analyses of acute myocardial infarction. Collectively, these studies suggest that DCB can be feasible when lesion preparation produces limited residual stenosis, no major flow-limiting dissection, and acceptable coronary flow. However, DCB has not established broad equivalence or superiority to contemporary drug-eluting stents (DES), particularly in unselected de novo disease. The evidence is limited by small samples, few clinical events, treatment-selection bias, bailout-stenting requirements, and substantial heterogeneity in clinical presentation, lesion type, procedural strategy, and follow-up. A focused systematic review and meta-analysis remains justified, provided that ACS and stable CAD, STEMI and NSTEMI, de novo lesions and in-stent restenosis, and randomized and observational evidence are analyzed separately.

Question: dcb vs stent in acs/cad. Is it worth conducting a meta analysis?

Read the full review

Brain Fog bei MECFS Evidenz für regionale Minderperfusion autonome Dysregulation und neuroenergetische Mechanismen

Die vorliegenden Befunde sprechen nicht für eine eindeutig belegte, dauerhaft bestehende regionale zerebrale Minderperfusion als primäre Ursache des Brain Fog bei ME/CFS. Kleine Studien mit SPECT, pseudo-continuous arterial spin labeling (PCASL) und ASL-fMRT beschrieben zwar regionale Perfusionsunterschiede, veränderte Erholungsreaktionen und funktionelle Netzwerkveränderungen, zeigten jedoch keine konsistente krankheitsspezifische Hypoperfusionssignatur. Direkter unterstützt wird ein dynamisches Modell, in dem orthostatische Belastung und autonome Dysregulation die zerebrale Perfusionsreserve, Autoregulation und kognitive Belastbarkeit beeinträchtigen. Metabolische und neuroenergetische Mechanismen bleiben plausibel, wurden durch die hier berücksichtigten Studien jedoch nicht direkt nachgewiesen. Insgesamt ist ein multifaktorielles Zusammenspiel aus autonomer Regulation, hämodynamischer Anpassung, neurovaskulärer Kopplung, Netzwerkfunktion und möglicherweise begrenzter metabolischer Belastbarkeit am wahrscheinlichsten.

Question: Brain-Fog bei ME/CFS: Mich würde interessieren, wie robust die Evidenz für die regionale Minderperfusion gegenüber metabolischen und autonomen Mechanismen ist

Read the full review

Resveratrol as a Context-Dependent Modulator of Sirtuin Signaling

The supplied evidence supports an association between resveratrol and sirtuin-related pathways, particularly SIRT1 and SIRT3, but does not justify describing resveratrol as a universal or consistently direct sirtuin activator. Biochemical and computational studies indicate that resveratrol can enhance SIRT1 activity under specific assay and substrate conditions by stabilizing interactions between SIRT1 and particular peptide substrates (PMID: 26109052; PMID: 27901083). Cellular and animal studies further connect resveratrol with SIRT1-dependent effects involving AMPK, mitochondrial function, inflammation, endothelial signaling, and protein expression. Evidence for SIRT3 includes functional protection in cardiac and intestinal injury models, with benefits lost after SIRT3 deficiency or silencing (PMID: 25527776; PMID: 37858064). However, several findings support indirect pathway modulation, and the physiological relevance of direct SIRT1 activation remains controversial. The cited material does not establish activation of SIRT2, SIRT4, SIRT5, SIRT6, or SIRT7 as a general effect.

Question: Does resveratrol activate sirtuins

Read the full review

Knowledge Gaps in 3′ UTR Regulation Alternative Polyadenylation and Disease

Messenger RNA 3′ untranslated regions (3′ UTRs) regulate transcript stability, localization, translation, surveillance, and degradation through sequence elements, RNA structure, polyadenylation status, and interactions with RNA-binding proteins and noncoding RNAs. Nevertheless, major uncertainties remain regarding how these regulatory features are integrated across cell types, subcellular compartments, developmental states, infections, and cancers. Alternative polyadenylation (APA) generates isoforms with different 3′ UTR lengths and can remove or expose regulatory elements, but the mechanisms determining poly(A)-site selection and the direct consequences of isoform switching remain incompletely defined. Additional unresolved areas include the functions of 3′ UTR-derived RNAs, the molecular basis of localized translation, the regulation of translation termination and RNA surveillance, and the links between altered 3′ UTR architecture and disease phenotypes. This review synthesizes these gaps and emphasizes the need for integrated measurements of RNA sequence, structure, localization, stability, translation, protein binding, and functional perturbation.

Question: 3' UTR region of mRNA AND knowledge gaps exist

Read the full review

NLRP3-Directed Therapeutic Strategies for Experimental Lung Inflammation and Acute Lung Injury

NLRP3 inflammasome activation contributes to experimental inflammatory lung injury through caspase-1 activation, gasdermin D–mediated pyroptosis, and release of interleukin (IL)-1β and IL-18. This review summarizes preclinical evidence for direct and indirect approaches targeting NLRP3-associated pathways. Direct inhibitors include MCC950, nimbolide, bigelovin, and the quinoxalinone compounds QK-3D and QK-3E. Additional strategies modulate upstream or parallel pathways involving mitochondrial metabolism, ROCK2/YAP signaling, NF-κB, Nrf2, Drp1/ROS, endoplasmic-reticulum stress, TXNIP, and autophagy. Across models of lipopolysaccharide (LPS)-induced acute lung injury, acute respiratory distress syndrome (ARDS), radiation-induced lung injury, and experimental silicosis, these interventions reduced inflammatory-cell recruitment, cytokine production, pyroptosis, tissue injury, and pulmonary edema. However, the evidence remains preclinical, and human efficacy, pharmacokinetics, long-term safety, and clinical utility have not been established.

Question: NLRP3 inhibitors for lung inflammation

Read the full review
NCBI Policies and Disclaimers
ByronInsight AG, Switzerland